Bacteria from the ocean floor help treat prostate cancer

Light-sensitive drugs made from sea-bottom bacteria will be injected into patients' blood vessels to treat prostate cancer without surgery.

Bacteria that live on the bottom of the ocean are discovered as a method of treating prostate cancer and can replace future harmful surgeries.

Non-surgical treatment is done by injecting a light-sensitive drug into a patient's blood vessel. The drug is then activated by a laser to destroy prostate cancer cells.

Bacterial light-sensitive drugs from the bottom of the ocean, tested for 413 patients at low risk of prostate cancer, 49% of them were relieved.

Professor Mark Emberton, head of the University of London's School of Health Sciences, said that with this new finding, there may be no need for future prostatectomy.(Photo: University of London).

Professor Mark Emberton, head of the University of London's School of Medical Sciences, who led the study, described the new method as a major breakthrough that could help prostate cancer patients not perform surgery. Harmful techniques to remove their prostate.

Professor Emberton compared this finding to breast cancer research, helping to reduce the need for mastectomy.

Laser beams have been shown to remove prostate cancer tumors by reacting to a light-sensitive drug derived from deep-sea bacteria.

"The result is great news for men with early prostate cancer, providing a treatment that can kill cancer without removing or destroying the prostate , " Professor Emberton speaks in a university journal.

STEBA Biotech biotech company in Luxembourg has funded research to use light-sensitive drugs and lasers to kill tumors.(Graphic image of treatment process: STEBA Biotech).

"In 1975, almost everyone with breast cancer was offered a complete mastectomy, but since stable treatments have improved, we rarely must remove the entire breast when treating this cancer, " he said: " In prostate cancer, we often remove or irradiate the entire prostate, so the success of preservation treatment. This new tissue is truly good news. "

This finding is published in the medical journal Lancet Oncology.